These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 23643487)

  • 1. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD.
    Mäkelä MJ; Backer V; Hedegaard M; Larsson K
    Respir Med; 2013 Oct; 107(10):1481-90. PubMed ID: 23643487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma.
    Capstick TG; Clifton IJ
    Expert Rev Respir Med; 2012 Feb; 6(1):91-101; quiz 102-3. PubMed ID: 22283582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsible prescribing for asthma and COPD.
    Pearce L
    Nurs Times; 2012 Nov 13-19; 108(46):12, 14, 16. PubMed ID: 23240219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled drug delivery in the hands of the patient.
    Lavorini F
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):414-8. PubMed ID: 25238005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for asthma and COPD.
    Treat Guidel Med Lett; 2013 Aug; 11(132):75-86; quiz following 86. PubMed ID: 23896773
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.
    Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K
    Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control.
    Donaire JG; Pérez DD; Hernández C; Cabestre R
    J Aerosol Med Pulm Drug Deliv; 2020 Jun; 33(3):153-160. PubMed ID: 31834826
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost saving of switching to equivalent inhalers and its effect on health outcomes.
    Bloom CI; Douglas I; Olney J; D'Ancona G; Smeeth L; Quint JK
    Thorax; 2019 Nov; 74(11):1078-1086. PubMed ID: 31383774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR).
    Lavorini F; Braido F; Baiardini I; Blasi F; Canonica GW;
    Pulm Pharmacol Ther; 2015 Oct; 34():25-30. PubMed ID: 26209820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SEPAR-ALAT consensus for inhaled therapies].
    ; ;
    Arch Bronconeumol; 2013 Jun; 49 Suppl 1():2-14. PubMed ID: 23967487
    [No Abstract]   [Full Text] [Related]  

  • 11. Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here?
    Dekhuijzen R; Lavorini F; Usmani OS; van Boven JFM
    J Allergy Clin Immunol Pract; 2018; 6(3):785-793. PubMed ID: 29339126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of inhaler devices in the management of airway disease.
    Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
    Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance on handheld inhalers in asthma and COPD guidelines.
    Dekhuijzen PN; Bjermer L; Lavorini F; Ninane V; Molimard M; Haughney J
    Respir Med; 2014 May; 108(5):694-700. PubMed ID: 24636812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD.
    Yu AP; Guérin A; de Leon DP; Ramakrishnan K; Wu EQ; Mocarski M; Blum SI; Setyawan J
    Respir Med; 2011 Dec; 105(12):1861-71. PubMed ID: 21807487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Adherence Barriers to Inhaled Medicines between Japanese Patients with Chronic Obstructive Pulmonary Disease and Asthma Evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) Questionnaire.
    Toyama T; Kawayama T; Kinoshita T; Imamura Y; Yoshida M; Takahashi K; Fujii K; Higashimoto I; Hoshino T
    Intern Med; 2019 Jan; 58(2):175-185. PubMed ID: 30210101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and opportunities in respiratory drug delivery devices.
    Nikander K
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1235-8. PubMed ID: 20939686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities in respiratory drug delivery.
    Pritchard JN; Giles RD
    Ther Deliv; 2014 Dec; 5(12):1261-73. PubMed ID: 25531928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parameters affecting inhalation therapy adherence in elderly patients with chronic obstructive lung disease and asthma.
    Turan O; Turan PA; Mirici A
    Geriatr Gerontol Int; 2017 Jun; 17(6):999-1005. PubMed ID: 27426234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to Inhaled Medications and its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients.
    Kim JA; Lim MK; Kim K; Park J; Rhee CK
    Clin Drug Investig; 2018 Apr; 38(4):333-340. PubMed ID: 29209982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Costs of illness for asthma and COPD in adults in Germany].
    Kirsch F; Teuner CM; Menn P; Leidl R
    Gesundheitswesen; 2013 Jul; 75(7):413-23. PubMed ID: 23553190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.